Drug class
Diagnostic radiopharmaceutical; fluorine-18-labelled choline analogue for PET imaging
Mechanism of action
Enters tumour cells through carrier-mediated choline transport, is phosphorylated intracellularly by choline kinase and can be incorporated into membrane phospholipids. Increased choline uptake and phosphorylation in proliferating tumour cells provide a PET imaging signal.
General use cases
- Investigational or specialised PET imaging of prostate cancer and other tumours; clinical use depends on local tracer preparation, validation and authorisation.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
